Topical Budesonide Treatment for Eosinophilic Esophagitis (EoE)
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to conduct a clinical trial of two formulations of budesonide
(nebulized/swallowed versus viscous/swallowed) in patients with EoE to determine if
medication contact time and distribution in the esophagus relates to treatment response. The
investigators will also determine if there is systemic absorption of these topical steroids.
The investigators hypothesize that tissue and symptom response will correlate with esophageal
medication contact time and distribution, and that significant systemic absorption will not
be seen.